There is one good advocacy group, the Alzheimer's Association based in the US. They produce good information materials and data about the disease. Among such data include:
* An estimated 10 million baby boomers will develop Alzheimer's.
* Starting this year, more than 10,000 baby boomers a day will turn 65. As these baby boomers age, one of out of eight of them will develop Alzheimer’s – a devastating, costly, heartbreaking disease. Increasingly for these baby boomers, it will no longer be their grandparents and parents who have Alzheimer’s – it will be them.
The Association recently produced a new report, Generation Alzheimer's: The Defining Disease of the Baby Boomers . Some data from the report says:
* 5.3 million people (in the US) have Alzheimer's
* costing some $172 billion a year
* it is the 6th leading cause of death in the US.
As I consistently argued in this blog and in my other writings, as diseases evolve, as lifestyle evolve, treatment should evolve, continuously, no let-up. Such treatment range from new medications to new knowledge of assistance by those who take care of Az patients. I also repeatedly argue that the role of private enterprises, the competition among them, is what will provide the continuing and long-term solution to various health problems that mankind will see. It's not more government regulations, more government provision of healthcare, more government taxation to finance those often choking regulators and bureaucrats, and expensive healthcare subsidies and entitlements.
2010 Report: Medicines in Development for Alzheimer's Diseases.
As I noted in my earlier paper, Going back to our roots, my father is now 83 years old, my mother is 77. I am glad that so far, they do not show symptoms of the Az disease. But a number of senior Filipinos that we sometimes fondly call as "ulyanin" (forgetful, irritable) may be showing symptoms of Az, whether mild or moderate. Severe cases would easily lead to death as the mind and body would ultimately shut down.
One important public health policy debate today or someday will be, by how much government healthcare expenditures should be devoted to Az disease treatment. Unlike mostly lifestyle-related diseases like lung cancer, heart diseases and diabetes, Az disease is due to nature, our biological clock ticking fast.
The cost of treatment of this and other diseases should be kept as low as possible. It can be done through more treatment and medicine innovation, and the fierce competition among innovator companies, and later on, among generic companies.
Related articles on innovation here will be:
On intellectual property abolition, part 3,
IPR and medicines, part 8